Bio-Rad Laboratories | BIO - Operating Profit

Stock Price
278.51
Daily Change
-1.48 -0.53%
Monthly
2.60%
Yearly
26.40%
Q2 Forecast
271.56

Bio-Rad Laboratories reported $63.9M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Agilent USD 353M 90M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bio Techne USD 54.46M 6.8M Dec/2025
Bio-Rad Laboratories USD 63.9M 13.2M Sep/2025
Bruker USD 76.3M 7.6M Dec/2025
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Danaher USD 1.5B 348M Dec/2025
General Electric Aerospace USD 1.77B 536M Dec/2025
Hologic USD 237M 16M Dec/2025
Illumina USD 256M 6M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Laboratory Of America USD 382M 15.3M Dec/2025
Merck USD 6.24B 318M Dec/2025
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Myriad Genetics USD -3M 20.3M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quest Diagnostics USD 386M 0 Dec/2025
Repligen USD 19.97M 7.29M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Siemens EUR 2.57B 3M Dec/2025
Standard Biotools USD -21.92M 1.55M Dec/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Tosoh JPY 25.15B 3.51B Dec/2025
Waters USD 270.52M 78.4M Dec/2025